intravenous human hepatitis b immunoglobulin therapy

The human hepatitis B immunoglobulin (HBIG) prepared by our company through cold ethanol fractionation and low pH viral inactivation has the following characteristics: l  The anti-HBs potency can effectively maintain at not less than 100 IU/ml during the shelf life; l  The product available in liquid preparation is easy to use; l  The content of polymers and dimers is not less than 90%; l  A large number of plasma units are pooled and used for the manufacture, and enable the final product to contain a wide spectrum of antibodies; l  Safe, efficacious, and seldom cause allergic reactions.